Back
Sarepta Therapeutics Stock Price Chart
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$53.80
Seasonality Move:
13.2%
7 Day Trial
ALL ACCESS PASS
$
7
Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.88 | Buy |
| 20-day SMA: | 60.79 | Sell |
| 50-day SMA: | 86.36 | Sell |
| 200-day SMA: | 118.53 | Sell |
| 8-day EMA: | 54.47 | Sell |
| 20-day EMA: | 62.27 | Sell |
| 50-day EMA: | 80.32 | Sell |
| 200-day EMA: | 108.23 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -10.07 | Sell |
| Relative Strength Index (14 RSI): | 31.45 | Sell |
| Chaikin Money Flow: | -1452145 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.97 - 79.33) | Sell |
| Bollinger Bands (100): | (79.54 - 128.22) | Sell |
Sarepta Therapeutics Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 53.79 while SRPT 8-day simple moving average is 52.88, which is a Buy signal.
-
The stock price of SRPT is 53.79 while Sarepta Therapeutics 20-day SMA is 60.79, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 86.36 while SRPT share price is 53.79, making it a Sell technically.
-
SRPT stock price is 53.79 and Sarepta Therapeutics 200-day simple moving average is 118.53, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a BuyThe current Sarepta Therapeutics [SRPT] share price is $53.79. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
5.2B
Price in USD:
53.79
Share Volume:
1.9M
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
48.01
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 53.79 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is not overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 53.79 while SRPT 8-day exponential moving average is 54.47, which is a Sell signal.
-
The stock price of SRPT is 53.79 while Sarepta Therapeutics 20-day EMA is 62.27, which makes it a Sell.
-
Sarepta Therapeutics 50-day exponential moving average is 80.32 while SRPT share price is 53.79, making it a Sell technically.
-
SRPT stock price is 53.79 and Sarepta Therapeutics 200-day simple moving average is 108.23, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is -10.07, suggesting Sarepta Therapeutics is a Sell
-
Sarepta Therapeutics Relative Strength Index (RSI) is 31.45, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (51.97 - 79.33), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (79.54 - 128.22), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.